Yun, Cho Rong
Practice Areas
Introduction
Cho Rong Yun received a B.S. from Chung Ang University College of Pharmacy, and a J.D. from Seoul National University School of law. Her practice focuses on intellectual property including pharmaceutical and biotechnology patents, digital health care, pharmaceuticals, medical devices, cosmetics, foods, and health functional foods. Based on her work experience and positive client reviews, she was selected as one of the Best Lawyers in the Medical & Bio practice by the JoongAng Ilbo & Korea In-house Counsel Association in 2023.
- 2019 University of California, Los Angeles, School of Law, LL.M.
- 2013 Seoul National University, School of Law, J.D.
- 2010 Chung-Ang University, College of Pharmacy, B.S.
- 2013-present Attorney at Law, Yulchon LLC
- 2021-Present Member, Health Care Data Deliberation Committee, Korea Health Information Service
- 2023-Present Member, Data Deliberation Committee, Gangwon Techno Park
- 2023-Present Director, Korean Intellectual Property Lawyers Association
- 2019-2020 Intern, Goodwin Procter LLP, New York Office
- 2022 Admitted to Bar , New York
- 2013 Admitted to Patent Bar , Republic of Korea
- 2013 Admitted to Bar , Republic of Korea
- 2010 Pharmacist , Republic of Korea
Korean, English
Representative Matters
- [Patent]
- 2024 Represented company C in the trial to confirm the scope of a patent and the infringement lawsuit related to biosimilar
- 2023 Represented the global semiconductor company G in patent infringement lawsuit and administrative lawsuit
- 2023 Represented company S in the invalidation trial and infringement civil/criminal lawsuits related to In Vitro Diagnostic Medical Device
- 2023 Advised a pharmaceutical company on the review/monitoring of patent invalidation/infringement related to newly developed pharmaceuticals
- 2023 Successfully represented the foreign chemical company C in a lawsuit seeking cancellation of patent invalidation decision
- 2023 Successfully represented the foreign chemical company D in a patent invalidation trial
- 2023 Represented company H in a pharmaceutical patent invalidation trial
- 2023 Successfully represented company Y and reached consensus in a lawsuit seeking payment of royalty related to joint development of pharmaceuticals
- 2023 Advised several pharmaceutical companies regarding the term extension of pharmaceuticals
Awards/Recognition
- 2026 Leading Lawyers, Healthcare Disputes, Legal Times
- 2026 Up and Coming, Intellectual Property, Chambers AP
- 2025-2026 Recommended, Licensing and Transactions, World Trademark Review (WTR) 1000
- 2024-2026 Bronze, Enforcement and Litigation, World Trademark Review (WTR) 1000
- 2024 Recommended, Transactions, World Trademark Review (WTR) 1000